DAVID GRAYZEL

Profile

First Name

: DAVID

Middle Name

:

Last Name

: GRAYZEL

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
ANNOVATION BIOPHARMA, INC.
NICHOLAS BARKER, CARL BERKE, JASON CAMPAGNA, JEAN-FRANCOIS FORMELA, ANKIT MAHADEVIA, DOUGLAS RAINES
EXECUTIVE OFFICER, DIRECTOR
ARTEAUS THERAPEUTICS, LLC
JEAN-FRANCOIS FORMELA, JEAN-FRANCOIS FROMELA, THOMAS SCHUETZ
EXECUTIVE OFFICER
ATLAS VENTURE FUND XI, L.P.
N/A ATLAS VENTURE ASSOCIATES XI, L.P., N/A ATLAS VENTURE ASSOCIATES XI, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, JASON RHODES
DIRECTOR
AKRIVEIA THERAPEUTICS, LLC
BENJAMIN AUSPITZ, THOMAS BECK, MICHAEL GLADSTONE, SIMON TOMLINSON
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND I, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, JASON RHODES
DIRECTOR
AFFINIA THERAPEUTICS INC.
ROBERT ABOUD, CHARLES ALBRIGHT, DIANA BRAINARD, PAULA COBB, RAMI DAOUD, CAROLE FAIG, ROBERT JOHNSON, PETRA KAUFMANN, EDWARD MATHERS, ROB MAY, RICK MODI, SEAN NOLAN, LAURA RICHMAN, ELLIOT SIGAL, ELLIOTT SIGAL, CAROLINE STOUT, LUC VANDENBERGHE, LUK VANDENBERGHE, ROBERT WEISSKOFF
EXECUTIVE OFFICER
ATLAS VENTURE FUND XII, L.P.
N/A ATLAS VENTURE ASSOCIATES XII, L.P., N/A ATLAS VENTURE ASSOCIATES XII, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, JASON RHODES
DIRECTOR
AEROVATE THERAPEUTICS, INC.
BENJAMIN DAKE, BENJAMIN T. DAKE, MAHA KATABI, JONATHAN LEFF, ANDREW LEVIN, JOSHUA RESNICK, JAMES SCHNEIDER
DIRECTOR
XILIO THERAPEUTICS, INC.
TIMOTHY CLACKSON, PAUL CLANCY, DANIEL CURRAN, PETER DUDEK, JOSEPH FARMER, DAVID GARDNER, ANDREW HACK, NANCY HONG, RACHEL HUMPHREY, DANIEL LYNCH, MICHAEL ROSS, RENE RUSSO, ROBERT WEISSKOFF
DIRECTOR
SANTI THERAPEUTICS, INC.
NATHANIEL BROOKS HORWITZ, SHELLEY CHU, MILIND DESHPANDE, ANDREW HEDIN, LORENCE KIM, ANDREW LEVIN, CHRISTOPHER O-DONNEL, CHRISTOPHER O-DONNELL, JIGAR RAYTHATHA, SIMON READ, JOSHUA RESNICK, PATRICK TROJER
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND II, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, JASON RHODES
DIRECTOR
TRIANA BIOMEDICINES, INC.
NATHANIEL BROOKS HORWITZ, SHELLEY CHU, MILIND DESHPANDE, ANDREW HEDIN, LORENCE KIM, ANDREW LEVIN, CHRISTOPHER O-DONNEL, CHRISTOPHER O-DONNELL, JIGAR RAYTHATHA, SIMON READ, JOSHUA RESNICK, PATRICK TROJER
EXECUTIVE OFFICER
ATLAS VENTURE FUND XIII, L.P.
N/A ATLAS VENTURE ASSOCIATES XIII, L.P., N/A ATLAS VENTURE ASSOCIATES XIII, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, JASON RHODES
DIRECTOR
COMANCHE BIOPHARMA CORP.
PAUL ANTINORI, ALLISON AUGUST, BRENDAN BULIK-SULLIVAN, ALLYSON FELIX, SCOTT GOTTLIEB, THOMAS SCOTT JOHNSON, ARTHUR LEVIN, MUZAMMIL MANSURI, CLIVE MEANWELL, KETAN PATEL, ANN TAYLOR, MICHAEL YOUNG
EXECUTIVE OFFICER
ATLAS VENTURE FUND XIV, L.P.
N/A ATLAS VENTURE ASSOCIATES XIV, L.P., N/A ATLAS VENTURE ASSOCIATES XIV, LLC, KEVIN BITTERMAN, BRUCE BOOTH, MICHAEL GLADSTONE, JASON RHODES
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-11-26 
2025-10-14
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-09-16 
2024-12-05
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-12-04 
2024-01-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
2022-04-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-28 
2022-03-03
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-03-02 
2022-02-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-28 
2021-10-01
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-09-30 
2021-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-03 
2021-05-06
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-20 
2021-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-23 
2021-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-20 
2020-08-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-05 
2020-06-04
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-05-20 
2020-03-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-12 
2019-01-02
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-12-07 
2018-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-23 
2017-06-30
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-06-28 
2014-04-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2012-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2012-07-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-20 
2011-07-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-20 
2011-05-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-02